Literature DB >> 8874551

Pontine glioma with osteoblastic skeletal metastases in a child.

Y Yanagawa1, T Miyazawa, S Ishihara, H Takiguchi, K Shima, S Terahata, S Tamai, H Chigasaki.   

Abstract

BACKGROUND: The development of systemic metastases from primary intracranial gliomas is rare. We report here a rare case of pontine glioma with osteoblastic skeletal metastases. CASE: This 12-year-old boy presented with a 4-month history of hoarseness, dysphagia, and a progressively ataxic gait. Cranial computed tomography (CT) and magnetic resonance imaging (MRI) revealed a brain stem tumor that was diagnosed as a low grade glioma by stereotactic biopsy. Twelve months later following chemotherapy and radiotherapy, neurologic examination and neuroradiologic studies disclosed a recurrence of the pontine glioma. Skeletal roentgenograms revealed widespread osteoblastic metastases in the skull, vertebral bodies, pelvis, and long bones. A specimen from the iliac bone demonstrated cells that were immunoreactive glial fibrillary acidic protein (GFAP). DISCUSSION: The mechanism of how glioma cells determine their biologic behavior at bony metastatic sites is not known. Infratentorial gliomas, which occur frequently in young patients and demonstrate active bony metabolism, may stimulate osteoblastic cells, and induce osteoblastic changes.

Entities:  

Mesh:

Year:  1996        PMID: 8874551     DOI: 10.1016/s0090-3019(96)00223-6

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.

Authors:  Sridharan Gururangan; Colleen A McLaughlin; James Brashears; Melody A Watral; James Provenzale; R Edward Coleman; Edward C Halperin; Jennifer Quinn; David Reardon; James Vredenburgh; Allan Friedman; Henry S Friedman
Journal:  J Neurooncol       Date:  2006-04       Impact factor: 4.130

Review 2.  Metaplastic bone formation in a low grade conus glioma: case report and review of the literature.

Authors:  Vitaly Siomin; Robert Willinsky; Patrick Shannon; Abhijit Guha
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.